Business ❯ Pharmaceutical Industry ❯ Vaccine Development ❯ Moderna Inc.

Market Performance

FDA Grants Full Approval to Moderna’s Pediatric COVID-19 Vaccine for At-Risk Children

Full licensure of Moderna’s Spikevax for at-risk children underscores federal policy narrowing pediatric COVID-19 vaccination during ongoing legal challenges.